- Conditions
- Osteomyelitis, Septic Arthritis, Pyomyositis
- Interventions
- Cefadroxil, Cephalexin
- Drug
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 6 Months to 18 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
Source: ClinicalTrials.gov public record
Updated Jun 1, 2021 · Synced May 21, 2026, 11:45 PM EDT